Greg Keenan serves as Executive at Aurinia Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Greg Keenan has executed 2 insider transactions totaling $210.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 2, 2026 involved selling 11,552 shares valued at $167.9K.
Greg Keenan currently holds 121,932 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Greg Keenan has been a net seller of AUPH stock. They have purchased $0 and sold $210.0K worth of shares.
Greg Keenan's most recent insider trade was on Feb 2, 2026, when they sold 11,552 shares at $14.53 per share.
Get notified when new Form 4 filings are submitted
| $10.50 |
| Discretionary |